Interpace Biosciences, Inc. (IDXG)

CIK 1054102 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Interpace Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 27, 20268-K0001493152-26-040329
Aug 26, 20268-K/A0001493152-26-040182
Aug 21, 20268-K0001493152-26-039530
Aug 20, 202640001493152-26-039495
Aug 20, 202640001493152-26-039496
Aug 20, 202640001493152-26-039507
Aug 20, 202640001493152-26-039504
Aug 20, 202640001493152-26-039528
Aug 20, 202640001493152-26-039505
Aug 12, 20268-K0001493152-26-037360
Aug 10, 202610-Q0001493152-26-036895
Jul 7, 2026DEFA14A0001493152-26-032377
Jul 7, 2026DEF 14A0001493152-26-032369
Jun 25, 2026PREM14A0001493152-26-029987
Jun 23, 2026PRE 14A0001493152-26-029801
May 14, 20268-K0001493152-26-023095
May 12, 202610-Q0001493152-26-022508
Apr 30, 202610-K/A0001493152-26-020590
Apr 1, 20268-K0001493152-26-014654
Mar 30, 202610-K0001493152-26-013646
Feb 17, 202640001493152-26-007093
Feb 4, 202640001493152-26-005161
Jan 20, 20268-K0001493152-26-002772
Dec 3, 20258-K0001493152-25-025960
Aug 8, 20258-K0001641172-25-022774